New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Serum biomarkers can differentiate psoriatic arthritis, rheumatoid arthritis

Serum biomarkers can differentiate psoriatic arthritis, rheumatoid arthritis

(HealthDay)—A serum protein biomarker panel can differentiate patients with early inflammatory arthritis with psoriatic arthritis (PsA) from those with rheumatoid arthritis (RA), according to a study
Immunology & Rheumatology June 06,2024
Serum biomarkers can differentiate psoriatic arthritis, rheumatoid arthritis

Serum biomarkers can differentiate psoriatic arthritis, rheumatoid arthritis

(HealthDay)—A serum protein biomarker panel can differentiate patients with early inflammatory arthritis with psoriatic arthritis (PsA) from those with rheumatoid arthritis (RA), according to a study
Immunology & Rheumatology June 06,2024
Rheumatoid arthritis predictors found in undifferentiated large joint arthritis

Rheumatoid arthritis predictors found in undifferentiated large joint arthritis

(HealthDay)—Autoantibody positivity and subclinical synovitis are independent predictors of rheumatoid arthritis (RA) among patients presenting with undifferentiated large joint arthritis, according t
Orthopedics & Sports medicine June 06,2024
Rheumatoid arthritis predictors found in undifferentiated large joint arthritis

Rheumatoid arthritis predictors found in undifferentiated large joint arthritis

(HealthDay)—Autoantibody positivity and subclinical synovitis are independent predictors of rheumatoid arthritis (RA) among patients presenting with undifferentiated large joint arthritis, according t
Orthopedics & Sports medicine June 06,2024
Potential biomarkers identified for neuropsychiatric symptoms of lupus

Potential biomarkers identified for neuropsychiatric symptoms of lupus

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA globally renowned expert in autoimmune diseases and systemic lupus erythematosus (SLE) at the University of Houston has identifi
Immunology & Rheumatology June 06,2024
Potential biomarkers identified for neuropsychiatric symptoms of lupus

Potential biomarkers identified for neuropsychiatric symptoms of lupus

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA globally renowned expert in autoimmune diseases and systemic lupus erythematosus (SLE) at the University of Houston has identifi
Immunology & Rheumatology June 06,2024
'Stepped' approach to exercise can help with arthritic knees

'Stepped' approach to exercise can help with arthritic knees

by Steven Reinberg Healthday Reporter(HealthDay)—Millions of Americans suffer from the pain of arthritic knees. But an innovative exercise regimen may help relieve discomfort and improve knee function
Orthopedics & Sports medicine June 06,2024
'Stepped' approach to exercise can help with arthritic knees

'Stepped' approach to exercise can help with arthritic knees

by Steven Reinberg Healthday Reporter(HealthDay)—Millions of Americans suffer from the pain of arthritic knees. But an innovative exercise regimen may help relieve discomfort and improve knee function
Orthopedics & Sports medicine June 06,2024
Subclinical synovitis may precede arthritis in anti-CCP2+ individuals

Subclinical synovitis may precede arthritis in anti-CCP2+ individuals

(HealthDay)—Subclinical synovitis frequently precedes the development of inflammatory arthritis among anti-cyclic citrullinated peptide (CCP) 2-positive at-risk individuals with musculoskeletal sympto
Orthopedics & Sports medicine June 06,2024
Subclinical synovitis may precede arthritis in anti-CCP2+ individuals

Subclinical synovitis may precede arthritis in anti-CCP2+ individuals

(HealthDay)—Subclinical synovitis frequently precedes the development of inflammatory arthritis among anti-cyclic citrullinated peptide (CCP) 2-positive at-risk individuals with musculoskeletal sympto
Orthopedics & Sports medicine June 06,2024
Light helps arthritis treatments target joints

Light helps arthritis treatments target joints

by Experimental BiologyA new light-activated drug delivery method could help confine arthritis treatments to the joints, greatly reducing side effects. The drug is activated using an external, low-pow
Orthopedics & Sports medicine June 06,2024
Light helps arthritis treatments target joints

Light helps arthritis treatments target joints

by Experimental BiologyA new light-activated drug delivery method could help confine arthritis treatments to the joints, greatly reducing side effects. The drug is activated using an external, low-pow
Orthopedics & Sports medicine June 06,2024
Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli
Immunology & Rheumatology June 06,2024
Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli
Immunology & Rheumatology June 06,2024
Lupus patients who take their medications lower their diabetes risk

Lupus patients who take their medications lower their diabetes risk

by University of British ColumbiaPatients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new
Immunology & Rheumatology June 06,2024
Lupus patients who take their medications lower their diabetes risk

Lupus patients who take their medications lower their diabetes risk

by University of British ColumbiaPatients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new
Immunology & Rheumatology June 06,2024
Study finds bacteria in milk linked to rheumatoid arthritis

Study finds bacteria in milk linked to rheumatoid arthritis

by University of Central FloridaSaleh Naser and his team UCF College of Medicine researchers has discovered a link between rheumatoid arthritis and Mycobacterium avium subspeciesparatubercu
Immunology & Rheumatology June 06,2024
Study finds bacteria in milk linked to rheumatoid arthritis

Study finds bacteria in milk linked to rheumatoid arthritis

by University of Central FloridaSaleh Naser and his team UCF College of Medicine researchers has discovered a link between rheumatoid arthritis and Mycobacterium avium subspeciesparatubercu
Immunology & Rheumatology June 06,2024
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

by Johns Hopkins University School of MedicineThe proposed binding site of the PAD4-activating antibody. The PAD4 enzyme is composed of two pieces (light gray and dark gray) that are connected in
Immunology & Rheumatology June 06,2024
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

by Johns Hopkins University School of MedicineThe proposed binding site of the PAD4-activating antibody. The PAD4 enzyme is composed of two pieces (light gray and dark gray) that are connected in
Immunology & Rheumatology June 06,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com